Skip to content
Clinical Trials – home
Centre Hospitalier Universitaire Grenoble Alpes
Sponsor

Centre Hospitalier Universitaire Grenoble Alpes

France Boulevard De La Chantourne, Cs 10217, La Tronche, 38043 Grenoble, France

About the sponsor

Clinical research spans stroke, subarachnoid hemorrhage, head trauma, herpes simplex virus encephalitis, and neurocognitive disorders with agitation in older adults. Additional interest includes acute anterior ischemic optic neuropathy and hyponatremia in the setting of cerebral hemorrhage.

  • Stroke and subarachnoid hemorrhage
  • Traumatic brain injury and head trauma
  • Encephalitis and acute neurocognitive disorders
  • Optic neuropathy

Research activity also covers symptom control and supportive care in acute neurological illness, including management of pain, agitation, and metabolic complications.

About Specializations

Centre Hospitalier Universitaire Grenoble Alpes runs clinical trials in conditions such as Subarachnoid haemorrhage, Breast cancer, Atrial fibrillation, Thrombosis prophylaxis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

12 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Breast cancer

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Edotreotide
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:HYDROGEN
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Escitalopram
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Propofol
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Urea
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bosentan
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Arteriosclerosis

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Midazolam
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).